| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |